Description

Research Overview

PT-141, also known as bremelanotide, is a synthetic melanocortin receptor agonist studied in laboratory models of melanocortin signalling, receptor-selectivity, and centrally mediated peptide response pathways. Investigational work frequently examines receptor pharmacology across the melanocortin system.

Mechanism of Interest

Research typically focuses on melanocortin receptor activation, cyclic peptide pharmacology, ligand selectivity, and downstream GPCR-mediated signalling.

Laboratory Specification

Laboratory Preparation

• Reconstitute using sterile bacteriostatic water where applicable and under clean laboratory technique.
• Prepare aliquots in line with internal laboratory SOPs.
• Avoid contamination during handling, dilution, transfer, and assay preparation.

Storage & Stability

Store cold and dry, protected from light. Refrigerate after reconstitution.

Batch & COA

• Batch-specific COA / analytical verification placeholder
• Analytical verification may include HPLC, MS, or other batch-appropriate methods.
• Batch identifiers should be recorded in laboratory documentation prior to use.

Research References

• https://pubchem.ncbi.nlm.nih.gov/compound/Bremelanotide
• https://pubmed.ncbi.nlm.nih.gov/?term=bremelanotide+PT-141
• https://en.wikipedia.org/wiki/Bremelanotide

Research Use Only

This product is supplied strictly for laboratory research purposes only. It is not intended for human consumption, clinical use, medical use, diagnostic use, or veterinary use. Purchasers are responsible for ensuring use by qualified researchers in controlled laboratory environments only.